Synergic prooxidant, apoptotic and TRPV1 channel activator effects of alpha-lipoic acid and cisplatin in MCF-7 breast cancer cells
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, vol.37, no.6, pp.569-577, 2017 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 37 Issue: 6
- Publication Date: 2017
- Doi Number: 10.1080/10799893.2017.1369121
- Journal Name: JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.569-577
- Süleyman Demirel University Affiliated: Yes
Abstract
Background: Resistance to cisplatin (Cisp) in the treatment of breast cancer is a major obstacle. Alpha-lipoic acid (ALA) has both antioxidant and oxidant properties. ALA has been used on stimulation mechanisms of apoptosis and oxidative stress in the treatment of cancer with a combination of chemotherapeutic agents, although its role on molecular mechanisms in the cancer cells has not been clarified yet. The aim of this study was to evaluate if a combination therapy of ALA with Cisp can alter the effect of this chemotherapy drug in the MCF-7 breast cancer cells.